Tris(dibenzylideneacetone)dipalladium (CAS 51364-51-3), universally abbreviated as Pd₂(dba)₃, is a zero-valent palladium complex in which two palladium atoms are coordinated to three dibenzylideneacetone ligands, giving the molecular formula C₅₁H₄₂O₃Pd₂ and a molecular weight of approximately 915.72. It is supplied as a purple to black or reddish-brown powder, and it is the most widely used Pd(0) source in synthetic organic chemistry precisely because it is not a single-purpose catalyst. Pd₂(dba)₃ functions as a catalyst precursor: in solution, the labile dba ligands dissociate, generating the coordinatively unsaturated Pd(0) species that enter the catalytic cycle of Suzuki-Miyaura, Heck, Buchwald-Hartwig, Negishi and related carbon-carbon and carbon-nitrogen bond-forming reactions. That precursor role is why the molecule sits at the centre of pharmaceutical process chemistry, agrochemical synthesis and the preparation of semiconducting polymers and liquid crystals. The commercial significance is disproportionate to its tonnage. Pd₂(dba)₃ is a high-value, low-volume specialty catalyst whose cost is driven by palladium content rather than by manufacturing scale, and whose performance in a reaction is determined not only by assay but by batch-to-batch consistency in palladium loading and residual dba. One review notes that variable palladium content across commercial Pd precatalysts—ranging from 10.5% to 20.5% w/w in related Pd(dba)₂ materials—causes loading errors in kilogram-scale cross-coupling reactions, a problem that directly affects whether a process delivers the intended impurity profile or requires re-optimization. For buyers, Pd₂(dba)₃ is therefore a qualification-sensitive raw material: the specification that matters is not “purity” in the abstract but palladium content within a defined window, dba stoichiometry, and lot-to-lot reproducibility under the actual coupling conditions.
Core Application Fields and Demand Architecture
Pd₂(dba)₃ demand concentrates in four functional arenas where the generation of a reactive Pd(0) species from a stable, isolable precursor is the enabling step: pharmaceutical and agrochemical process chemistry, materials science and organic electronics, specialty ligand and precatalyst development, and academic and contract research.
In pharmaceutical and agrochemical process chemistry, Pd₂(dba)₃ is the default Pd(0) source for cross-coupling steps that form C–C and C–N bonds in complex molecules. Heraeus lists its use in the synthesis of pesticides, herbicides and fungicides as well as in the synthesis of active pharmaceutical ingredients (APIs). The reactions involved are the workhorses of modern medicinal and process chemistry: Suzuki-Miyaura couplings of aryl halides with aryl or heteroaryl boronic acids, Heck couplings of aryl halides with olefins, Buchwald-Hartwig aminations for C–N bond formation, and Negishi couplings of organozinc reagents. In process chemistry, Pd₂(dba)₃ is typically paired with a supporting ligand—phosphine, N-heterocyclic carbene or Buchwald-type ligand—that controls the active catalytic species, and the precursor’s role is to deliver Pd(0) cleanly and reproducibly at the start of the reaction. This is the segment where the commercial consequences of specification variability are most acute: a change in palladium loading or dba ratio can shift the ligand-to-palladium ratio in situ, alter the rate of catalyst activation, and introduce variability into a validated process. The demand is not price-elastic in the conventional sense, because the catalyst cost is a small fraction of the value of the API batch, but it is specification-elastic, because a failed coupling step can cost far more than the catalyst itself.
In materials science and organic electronics, Pd₂(dba)₃ is used in the preparation of semiconducting polymers processed from non-chlorinated solvents into high-performance thin-film transistors, and in the synthesis of polymer bulk-heterojunction solar cells. It is also used as a precursor for palladium complex compounds and in the production of liquid crystals. These applications are smaller in volume than pharmaceutical synthesis but place a premium on metal purity and on the absence of residual ligands or dba-derived impurities that could affect device performance. The materials-science demand is growing with the development of printable electronics and organic photovoltaics, although it remains a specialty niche relative to pharmaceutical process chemistry.
Specialty ligand and precatalyst development is a third arena. Pd₂(dba)₃ is the starting material for preparing defined Pd(0)–ligand complexes and for catalyst screening across ligand libraries. In this context, the precursor’s dba content and palladium loading directly affect the stoichiometry of the resulting complex, and suppliers that can provide lot-specific analytical data on palladium and dba support the reproducibility of ligand screening programs.
Academic and contract research demand completes the picture. Pd₂(dba)₃ is a standard reagent in synthetic methodology laboratories and in contract research organizations serving the pharmaceutical and agrochemical industries. This segment is highly fragmented and price-sensitive at the gram scale, but it seeds the process chemistry that later converts to kilogram-scale demand as reactions are optimized and scaled.
Regulatory Profile: A Palladium Complex Defined by Metal Content, Sensitization and Workplace Handling
Pd₂(dba)₃ is not a solvent or a high-production-volume commodity, and its regulatory profile reflects that: the operative constraints are workplace handling, metal-content classification and the practical distinction between catalyst-grade material and research-grade reagent.
In the European Union, the substance is a palladium coordination complex. REACH registration is not available for the substance as such because the annual tonnage falls below the registration threshold or the use is exempt, and the safety data sheet explicitly states that no registration number is available for this reason. The CLP classification reported in supplier SDS documentation includes Skin Sensitization Category 1 (H317) and long-term aquatic hazard Category 2 (H411) for the non-adducted complex, with the chloroform adduct additionally classified for acute oral toxicity and carcinogenicity. The implication for buyers is that the non-adducted Pd₂(dba)₃ is not a CMR substance in the same sense as the chloroform adduct, but it is a skin sensitizer and an aquatic hazard, and it must be handled with appropriate engineering controls and PPE. Palladium metal and its compounds are also subject to occupational exposure limits in many jurisdictions, and downstream pharmaceutical manufacturers typically impose additional metal-residue specifications on the final API rather than on the catalyst itself.
In the United States, Pd₂(dba)₃ is on the TSCA Inventory and is regulated under the OSHA Hazard Communication Standard. The chloroform adduct carries a “suspected of causing cancer” classification (H351) in Thermo Fisher’s SDS, reflecting the chloroform component rather than the palladium complex itself, and this distinction matters for buyers who need to avoid chlorinated-solvent adducts in process chemistry. The non-adducted Pd₂(dba)₃ is the preferred form for pharmaceutical processes where residual chloroform is unacceptable, and suppliers that can document the absence of chloroform adduct are better positioned for API synthesis accounts.
For Russia and the EAEU, Pd₂(dba)₃ is imported as a laboratory and process catalyst. There is no meaningful domestic production of the complex, and the market depends on imports from European, Japanese and Chinese suppliers. The practical compliance requirements are a Russian-language SDS, a certificate of analysis reporting palladium content and assay, and transport documentation consistent with the classification of the material as a metal complex with sensitizing properties. The absence of a dedicated EAEU monograph for Pd₂(dba)₃ means that buyers rely on supplier specifications and on their own incoming quality control, which raises the importance of lot-specific analytical data.
Global Supply Structure and Manufacturer Differentiation
Global Pd₂(dba)₃ supply is a specialty segment within the broader precious-metal catalyst market, and it is structured around a small number of precious-metals refiners and catalyst manufacturers with the capability to synthesize and purify palladium complexes reproducibly.
The suppliers identified in product and market listings include Heraeus Precious Metals, Umicore, Johnson Matthey, Thermo Fisher (Alfa Aesar), Sigma-Aldrich, ChemImpex, Biosynth and a cohort of Chinese catalyst producers concentrated in palladium chemistry. Heraeus positions its material for C–C coupling markets with best delivery to APAC and EMEA, and lists a minimum order quantity of 2 kg for its standard grade, which indicates that the commercial segment is oriented toward process-scale customers rather than gram-scale research supply. The Chinese producers listed in ChemicalBook and CPhI exhibitor listings serve a mix of domestic process chemistry and export markets, and the presence of multiple suppliers at the gram-to-kilogram scale reflects the fragmentation of the research and specialty synthesis market.
Differentiation operates on three axes. The first is palladium content control. Commercial specifications for Pd₂(dba)₃ range from approximately 18.5–22.0% palladium in Heraeus’s specification to 20.0–24.2% in VWR’s specification and 20.0–22.5% in Biosynth’s certificate of analysis, with some suppliers offering material at ≥19% palladium and ≥81.75% purity. This spread is not merely a catalogue inconsistency; it reflects different stoichiometries, residual solvent content and the presence or absence of co-crystallized dba. A supplier that reports palladium content on a lot-specific basis and holds it within a narrow window gives the process chemist a predictable loading factor, while a supplier that reports only a wide range forces the buyer to re-assay every lot. The second axis is adduct control. Pd₂(dba)₃ is commercially available as the unsolvated complex and as chloroform, dichloromethane or other solvent adducts. The adducted forms are convenient for handling and stability but introduce chlorinated solvents that are unacceptable in many pharmaceutical processes. A supplier that can offer the unsolvated complex with documented residual solvent below the relevant ICH Q3C limit serves the process-chemistry segment that the adduct suppliers cannot. The third axis is documentation and lot-level traceability. For process chemistry, the certificate of analysis must connect palladium content, assay, appearance and residual solvent to the specific lot, and the supplier must be able to provide change-control notification if the manufacturing route or purification is modified. In a market where the molecule is a coordination complex rather than a single pure compound, documentation depth is a genuine differentiator.
For Russian and EAEU buyers, the supply structure creates a specific dependency. The major precious-metals catalyst producers are based in Europe, Japan and the United States, and the Chinese producers offer a range of grades and palladium contents. The absence of domestic production means that Russian process chemistry and research buyers depend on imported material, and the practical qualification burden falls on the buyer’s incoming QC. This is the context in which a supplier with lot-specific palladium data, unsolvated-grade availability and Russian-language SDS support becomes more valuable than a low-cost spot offer.
Regional Demand Dynamics
Pd₂(dba)₃ demand follows the geography of pharmaceutical process chemistry, materials science research and specialty synthesis rather than the geography of palladium mining.
Europe and North America are the mature, specification-intensive markets. They concentrate the process chemistry groups of large pharmaceutical companies, the contract development and manufacturing organizations that serve them, and the materials-science and organic-electronics research clusters that use Pd₂(dba)₃ as a precursor. Demand in these regions is stable and specification-driven, with the unsolvated complex and low-residual-solvent grades preferred for API synthesis. The presence of Heraeus, Umicore and Johnson Matthey provides regional supply security, but the specialty nature of the product means that even large buyers qualify a limited number of sources.
Asia-Pacific is the fastest-growing region, supported by the expansion of pharmaceutical process chemistry and generic API manufacturing in China, India, Japan and South Korea, and by the growth of organic electronics and display materials in the region. Heraeus’s designation of APAC as a best-delivery market reflects this shift. Chinese catalyst producers serve both domestic process chemistry and export markets, and the region’s demand is bifurcated between research-grade material at the gram scale and process-grade material at the kilogram scale. The growth in biosimilar and generic API manufacturing is increasing the number of cross-coupling steps performed at commercial scale, which pulls through demand for reproducible Pd(0) precursors.
Russia and the EAEU form a smaller, import-dependent contour. Demand is concentrated in pharmaceutical research and process development, academic synthesis and specialty chemical production. Domestic production of Pd₂(dba)₃ does not exist at commercial scale, and buyers depend on imported material from European, Japanese and Chinese sources. The practical consequence is that supplier selection must carry the full documentation burden: lot-specific palladium content, assay, residual solvent data and Russian-language SDS.
Future Outlook and Strategic Imperatives
The Pd₂(dba)₃ market will grow at a moderate rate in volume, tracking the expansion of cross-coupling chemistry in pharmaceutical and agrochemical process development rather than any single end-market cycle. The quality of that growth is shifting toward reproducibility and documentation, because the molecule is moving from a research reagent to a qualified process raw material.
Three structural forces will shape competition. First, palladium price volatility and supply-chain concentration will continue to make palladium content a commercial variable, not just a technical specification. Suppliers that can document and hold palladium content within narrow windows, and that offer flexible package sizes from grams to kilograms, will be better positioned than those offering a single catalogue grade with a wide assay range. Second, the shift toward unsolvated and low-residual-solvent grades will accelerate as pharmaceutical process chemistry moves away from chlorinated adducts and toward ICH Q3C-compliant raw materials. Suppliers that can offer the unsolvated complex with documented residual solvent below the relevant limits will serve the highest-value segment. Third, the growth of organic electronics and printable materials will add a materials-science demand stream that values metal purity and lot-to-lot consistency, even at smaller volumes.
For Russian and EAEU buyers, the strategic implication is that Pd₂(dba)₃ procurement should be treated as a specification partnership rather than a catalogue purchase. A failed lot—whether from palladium content outside the validated window, residual chloroform above the process limit or an incomplete certificate of analysis—does not simply cost the price of the bottle; it can invalidate a coupling step, delay a process qualification or force a re-optimization of catalyst loading. The lowest-risk supplier is the one that can provide lot-specific palladium content, assay, residual solvent data and Russian-language SDS, and that can hold those specifications across shipments.
Shanghai XinChem Co., Ltd. (XinChem)
As a world-leading supplier of organic chemicals, Shanghai XinChem Co., Ltd. (XinChem) offers Tris(dibenzylideneacetone)dipalladium (CAS 51364-51-3) in catalyst-grade and research-grade specifications, serving pharmaceutical process chemistry, agrochemical synthesis, materials science and specialty catalyst development. Our Pd₂(dba)₃ is supplied with lot-specific palladium content, controlled assay and documented residual solvent, supported by the analytical documentation and Russian-language SDS that process-scale cross-coupling qualification requires.
Technical and Quality Advantages
Lot-Specific Palladium Content: Pd₂(dba)₃ performance in a cross-coupling reaction depends on the palladium loading factor, not on a generic “purity” figure. XinChem supplies material with palladium content determined and reported on a lot-by-lot basis, so that process chemists can calculate catalyst loading against the actual palladium delivered rather than a catalogue midpoint, reducing the loading errors that variable Pd content causes in kilogram-scale couplings.
Unsolvated Grade Availability: The unsolvated Pd₂(dba)₃ complex is available for pharmaceutical and materials applications where chloroform or dichloromethane adducts are unacceptable. This allows buyers to avoid chlorinated-solvent residues that would otherwise require additional control against ICH Q3C limits and simplifies the solvent-compliance profile of the final process.
Assay and Residual Solvent Documentation: The certificate of analysis reports assay, appearance and residual solvent data alongside palladium content, so that the buyer can verify the specification against their process requirements without re-assaying every lot. For process chemistry, this documentation is the basis for incoming qualification and for change-control decisions.
Regulatory and Language Support: Safety data sheets are available in English and Russian, with documentation covering the sensitization and aquatic-hazard classification of the complex and the distinction between the unsolvated and adducted forms. The regulatory team tracks changes in classification and transport requirements so that buyers receive advance notice of specification or labelling impacts.
Packaging and Logistics Flexibility
Pd₂(dba)₃ is available in sealed 1 g, 5 g and 25 g containers for research and pilot qualification, and in larger package sizes for process-scale requirements. For Russia and EAEU destinations, XinChem arranges logistics with appropriate customs and transport documentation, including Russian-language SDS and certificate-of-analysis support, to reduce clearance friction for a specialty catalyst that is entirely import-dependent in the region.
Application Support and Supply Reliability
XinChem’s technical team assists with grade selection for Suzuki, Heck, Buchwald-Hartwig and Negishi couplings, with the choice between solvated and unsolvated forms, and with the palladium-content and residual-solvent documentation that process qualification demands. Supply schedules accommodate both qualification quantities and recurring process-scale volumes, with safety stock held to buffer the concentration of global precious-metals catalyst capacity and freight variability on Asia–Russia and Asia–Europe lanes.
Why Choose XinChem
Expertise: Deep experience in precious-metal catalysts and cross-coupling chemistry, with application knowledge spanning pharmaceutical process development, agrochemical synthesis and materials science.
Consistency: Lot-specific control of palladium content, assay and residual solvent—the parameters that determine whether Pd₂(dba)₃ activates cleanly in a validated coupling or introduces loading-dependent variability.
Compliance Readiness: Documentation structured around lot-level palladium data, unsolvated-grade availability and the sensitization and aquatic-hazard classification, with Russian-language SDS support.
Responsiveness: Direct technical and commercial access, with order structures from gram-scale qualification to process-scale supply.
Contact us now to discuss your Pd₂(dba)₃ requirements and request a specification sheet or qualification sample.
Website: www.xinchem.com
Email: sales1@xinchem.com
WhatsApp: +86 18049800532
Post time: Oct-28-2026